Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Low risk of severe hypoglycaemia in patients with type 2 diabetes mellitus starting insulin therapy with premixed insulin analogues BID in outpatient settings
International Journal of Clinical Practice, Volume 66, No. 11, Year 2012
Notification
URL copied to clipboard!
Description
Aims: The choice of insulin at initiation in type 2 diabetes remains controversial. The aim of this study was to assess the occurrence of self-reported severe hypoglycaemia associated with premixed insulin analogues in routine clinical care. Methods: A 12-month, prospective, observational, multicentre study in patients starting a commonly prescribed premixed insulin analogue (either insulin lispro 25/75 or biphasic insulin aspart 30/70, twice daily) after suboptimal glycaemic control on oral antidiabetic agents. Treatment decisions were made solely in the course of usual practice. Results: Study follow-up was completed by 991 (85.5%) of the 1150 patients enrolled. At baseline, mean (SD) age was 57.9 (10.1) years; mean diabetes duration was 9.2 (5.9) years; mean haemoglobin A1c (HbA1c) was 9.9 (1.8) % and the rate of severe hypoglycaemia was 0.03 episode/patient-year. At 12 months, the rate of severe hypoglycaemia was 0.04 episode/patient-year (95% CI 0.023, 0.055 episode/patient-year) and mean insulin dose was 41.5 (19.4) units. Changes from baseline to 12 months for mean fasting plasma glucose and HbA 1c were -5.1 mmol/l and -2.5%, respectively. Conclusions: After initiation of premixed insulin analogues in patients with type 2 diabetes in real-world settings, the incidence of severe hypoglycaemia was lower than expected from previously reported studies. © 2012 Blackwell Publishing Ltd.
Authors & Co-Authors
Pirags, Valdis
Latvia, Riga
Latvijas Universitāte
El Damassy, Hussien
Egypt, Cairo
Ain Shams University
Da̧browski, Mariusz
Poland, Rzeszow
University of Rzeszów
Gonen, Mustafa Sait
Turkey, Selçuklu
Selçuk Üniversitesi
Račická, Evá
Czech Republic, Ostrava
Diabetologická a Interní Ambulance Ostrava
Martinka, Emil
Slovakia, Ľubochňa
National Institute of Endocrinology and Diabetology
Giaconia, Joseph M.
United States, Morrisville
Syneos Health, Inc.
Stefański, Adam
Poland, Warsaw
Eli Lilly Polska Sp. z O.o.
Statistics
Citations: 8
Authors: 8
Affiliations: 8
Identifiers
Doi:
10.1111/j.1742-1241.2012.03001.x
ISSN:
13685031
e-ISSN:
17421241
Research Areas
Health System And Policy
Noncommunicable Diseases
Study Design
Cohort Study